373 related articles for article (PubMed ID: 30341577)
21. Current approach to treatments for prolactinomas.
Tirosh A; Shimon I
Minerva Endocrinol; 2016 Sep; 41(3):316-23. PubMed ID: 26399371
[TBL] [Abstract][Full Text] [Related]
22. Update on prolactinomas. Part 1: Clinical manifestations and diagnostic challenges.
Wong A; Eloy JA; Couldwell WT; Liu JK
J Clin Neurosci; 2015 Oct; 22(10):1562-7. PubMed ID: 26256063
[TBL] [Abstract][Full Text] [Related]
23. Bone density in women with prolactinoma treated with dopamine agonists.
Naliato EC; Violante AH; Caldas D; Farias ML; Bussade I; Lamounier Filho A; Loureiro CR; Fontes R; Schrank Y; Loures T; Colao A
Pituitary; 2008; 11(1):21-8. PubMed ID: 17661178
[TBL] [Abstract][Full Text] [Related]
24. Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature.
Kuhn E; Weinreich AA; Biermasz NR; Jorgensen JOL; Chanson P
Eur J Endocrinol; 2021 May; 185(1):99-108. PubMed ID: 33914699
[TBL] [Abstract][Full Text] [Related]
25. The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.
Soule SG; Farhi J; Conway GS; Jacobs HS; Powell M
Clin Endocrinol (Oxf); 1996 Jun; 44(6):711-6. PubMed ID: 8759184
[TBL] [Abstract][Full Text] [Related]
26. [Hyperprolactinemia].
Müller OA; von Werder K
Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
[No Abstract] [Full Text] [Related]
27. The Role of Surgery in the Management of Prolactinomas.
Donoho DA; Laws ER
Neurosurg Clin N Am; 2019 Oct; 30(4):509-514. PubMed ID: 31471058
[TBL] [Abstract][Full Text] [Related]
28. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
[TBL] [Abstract][Full Text] [Related]
29. Predictors of dopamine agonist resistance in prolactinoma patients.
Vermeulen E; D'Haens J; Stadnik T; Unuane D; Barbe K; Van Velthoven V; Gläsker S
BMC Endocr Disord; 2020 May; 20(1):68. PubMed ID: 32429916
[TBL] [Abstract][Full Text] [Related]
30. Pregnancy and Tumor Outcomes in Women with Prolactinoma.
Araujo B; Belo S; Carvalho D
Exp Clin Endocrinol Diabetes; 2017 Nov; 125(10):642-648. PubMed ID: 28704852
[No Abstract] [Full Text] [Related]
31. 10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas.
Andereggen L; Frey J; Andres RH; El-Koussy M; Beck J; Seiler RW; Christ E
Endocrine; 2017 Jan; 55(1):223-230. PubMed ID: 27688009
[TBL] [Abstract][Full Text] [Related]
32. Macroprolactinemia in patients with prolactinomas: prevalence and clinical significance.
Elenkova A; Genov N; Abadzhieva Z; Kirilov G; Vasilev V; Kalinov K; Zacharieva S
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):201-5. PubMed ID: 23595795
[TBL] [Abstract][Full Text] [Related]
33. Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma.
Freeman B; Levy W; Gorman JM
J Psychiatr Pract; 2007 Mar; 13(2):120-4. PubMed ID: 17414690
[No Abstract] [Full Text] [Related]
34. Pregnancy-induced changes in prolactinomas as assessed with computed tomography.
Toffle RC; Webb SM; Tagatz GE; Taylor S; Nagel TC; Campbell B; Phipps W; Okagaki T
J Reprod Med; 1988 Oct; 33(10):821-6. PubMed ID: 3193413
[TBL] [Abstract][Full Text] [Related]
35. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
[TBL] [Abstract][Full Text] [Related]
36. Concomitant Cushing's Disease and Marked Hyperprolactinemia: Response to a Dopamine Receptor Agonist.
Shiraishi J; Koyama H; Shirakawa M; Ishikura R; Okazaki H; Kurajoh M; Shoji T; Moriwaki Y; Yamamoto T; Namba M
Intern Med; 2016; 55(8):935-41. PubMed ID: 27086808
[TBL] [Abstract][Full Text] [Related]
37. Prolactinoma in pregnancy.
Molitch ME
Best Pract Res Clin Endocrinol Metab; 2011 Dec; 25(6):885-96. PubMed ID: 22115164
[TBL] [Abstract][Full Text] [Related]
38. Prolactinomas in infertile women: clinical and endocrine characteristics before and after 24 months of treatment with bromocriptine.
Hajder M; Hajder E; Dervisefendic M; Samardzic R; Alic E
Med Arch; 2013; 67(3):181-4. PubMed ID: 23848038
[TBL] [Abstract][Full Text] [Related]
39. Anejaculation as the presenting feature of pituitary microadenoma.
Nair S; Milsom S
Fertil Steril; 2008 Nov; 90(5):2012.e21-3. PubMed ID: 18394608
[TBL] [Abstract][Full Text] [Related]
40. A survey of dopamine agonist withdrawal policy in UK endocrinologists treating patients with prolactinomas. Clinical Endocrinology 58, 111.
Wass J; Turner H
Clin Endocrinol (Oxf); 2003 Sep; 59(3):406. PubMed ID: 12919169
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
